Gladstone NOW: The Campaign Join Us on the Journey✕
Diagnoses of autism spectrum disorder, or ASD, have been rising over the past decades, with one in 36 children identified with the condition in 2020 compared to one in 150 back in 2000, according to the US Centers for Disease Control and Prevention. Nevan Krogan, PhD, senior investigator at Gladstone Institutes and director of the Quantitative Biosciences Institute at UC San Francisco, shares new research on genetic changes that contribute to ASD.
In this video, Gladstone scientists Emma Dann and Ronghui Zhu explain how their new study offers a powerful framework for designing cancer immunotherapies and treating autoimmune conditions.
Nearly 20 years after his landmark study uncovered novel roles of tau in Alzheimer’s disease, Gladstone's Lennart Mucke shares his perspective on new clinical data that could transform the future of brain health.
Mucke Lab Alzheimer’s Disease Gladstone Experts Neurological Disease News ReleaseIn this video, Katie Pollard and Deepak Srivastava explain how Gladstone scientists are combining AI models with novel tools in the lab to finally decode the entire human genome.
Gladstone Experts Pollard Lab Srivastava Lab AI